Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
07/2008
07/15/2008US7399771 Piperidine derivatives as CCR5 inhibitors
07/15/2008US7399320 Dyeing, bleaching keratinous fibers (hair); 2-[5-(N-methyl-2-pyridinylidene)-3-methyl-1-formazano]-N-methylpyridinium chloride
07/10/2008WO2008083124A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
07/10/2008WO2008082041A1 Process for preparing lercanidipine hydrochloride
07/10/2008WO2008081726A1 Process for production of amide or lactam
07/10/2008WO2008081477A1 3-aryloxy 3-substituted propanamines
07/10/2008WO2008080934A1 Stable s-nitrosothiols, method of synthesis and use
07/10/2008WO2008080601A2 Process for the preparation of loperamide
07/10/2008WO2007115821A3 Organic compounds
07/10/2008WO2007062335A8 New pleuromutilin derivative and its use
07/10/2008US20080167471 comprising 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid hydrochloride; antiallergic agents and bronchodilators
07/10/2008US20080167470 Process of enantiomeric resolution of D,L-(+_)-threo-methylphenidate
07/10/2008US20080167469 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate
07/10/2008US20080167352 3-(4-Chloro-phenyl)-adamantane-1-carboxylic acidisopropylamide; antiproliferative, antiinflammatory agent, angiogenesis inhibitor; sphingolipid-derived signaling pathway; coupling acid or acylhalide of phenyl-adamantane derivatives with aminoalkyl-pyridine
07/10/2008US20080167347 Antidiabetic, antiproliferative, anticancer agents; benzanilide derivatives
07/10/2008US20080167332 Novel Compounds 243
07/10/2008US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases
07/10/2008US20080166332 Methods of Treatment of Amyloidosis Using Subsituted Ethanolcyclicamine Aspartyl Protease Inhibitors
07/10/2008CA2674237A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
07/09/2008EP1940790A2 Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
07/09/2008EP1940783A1 Process for preparing n, n-substituted carbamoyl halides
07/09/2008EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors
07/09/2008EP1720825B1 Anthranilic acid derivatives, methods for their preparation and use as dhodh inhibitors
07/09/2008EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms
07/09/2008EP1220842B1 Cyclic amine compound as ccr5 antagonist
07/09/2008EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
07/09/2008CN101215285A Polyhydroxy substituted octahydroindolizidine and synthesis method thereof
07/09/2008CN101215258A Dihydropyridines calcium antagonist compounds, preparation method and medical use thereof
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/09/2008CN100400519C N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
07/09/2008CN100400511C Cathepsin S inhibitors
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/08/2008US7396930 making spiro(benzo(c)thiophene-1 (3H),4'-piperidine) derivatives; involves reacting a mercapto compound with a 2-halophenylalkyl halide, reacting with an alkyllithium, then N-ethoxycarbonyl-4-piperidone, dehydration and cyclization; industrial scale; novel intermediates to neurokinin receptor antagonist
07/08/2008US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases
07/08/2008US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/03/2008WO2008079284A1 Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds
07/03/2008WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
07/03/2008WO2008077811A1 Spiro-piperidine derivatives
07/03/2008WO2008077810A2 Spiro-piperidine derivatives
07/03/2008WO2008057721A3 Water tolerant emulsion stabilizers
07/03/2008WO2008041184A3 Muscarinic receptor antagonists
07/03/2008WO2007114902A3 Alkylthiobenzylpiperidine compounds
07/03/2008US20080161577 Muscarinic receptor antagonists; longer duration of action; side effect reduction; high potency; chronic obstructive pulmonary disease; asthma; inhalation; 2-[(S)-1-(8-Methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide
07/03/2008US20080161576 Mixing a quaternary ammonium salt with an organic solvent in a vessel under an inert atmosphere; used as phase transfer catalysts; salts are substantially free of degradation products and are in a form suitable for use with commercial scale reactions
07/03/2008US20080161374 Pyrazole compounds and uses related thereto
07/03/2008US20080161354 Stable s-nitrosothiols, method of synthesis and use
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes
07/03/2008DE102006061533A1 Verfahren zur Herstellung von 2-Aminomethylpiperidin A process for the preparation of 2-aminomethylpiperidine
07/03/2008CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure
07/03/2008CA2674518A1 Spiro-piperidine derivatives
07/03/2008CA2673307A1 Spiro-piperidine derivatives
07/03/2008CA2673233A1 Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds
07/03/2008CA2664118A1 Protease inhibitors
07/02/2008EP1939189A1 Derivative having ppar agonistic activity
07/02/2008EP1939179A1 Stable S-nitrosothiols, method of synthesis and use
07/02/2008EP1939178A1 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine or hydrochloride thereof
07/02/2008EP1939177A2 Method for manufacturing 2-aminomethylpiperidin
07/02/2008EP1937726A1 Inhibition of polymerisation
07/02/2008EP1937252A2 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
07/02/2008EP1830841B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
07/02/2008EP1692127B1 Triphenylethylene compounds as selective estrogen receptor modulators
07/02/2008EP1633702B1 Protease inhibitors
07/02/2008EP1496838A4 Substituted amides
07/02/2008EP1214287B1 Amides as inhibitors for pyruvate dehydrogenase
07/02/2008CN101213185A Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
07/02/2008CN101212974A 4-fluoro-piperidine T-type calcium channel antagonists
07/02/2008CN101209991A Method for preparing S-(-)-amlodipine
07/02/2008CN101209990A Resolution method for 3-piperidine formic acid ester
07/02/2008CN101209989A Method for manufacturing 2-aminomethylpiperidin
07/02/2008CN100398539C Synthesis of heteroaryl acetamides
07/02/2008CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5
07/02/2008CN100398534C New method of synthesizing thalidomide and its derivative
07/02/2008CN100398533C Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
07/01/2008US7393873 Arylsulfonamide derivatives
07/01/2008US7393861 Derivatives of 4-aminopiperidine and their use as a medicament
07/01/2008US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis
06/2008
06/26/2008WO2008075077A1 Piperidine derivatives for the treatment of obesity
06/26/2008WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors
06/26/2008WO2008075064A1 Piperidine derivatives for the treatment of obesity
06/26/2008WO2008075040A2 Radioactive pet agents for imaging ccr5 in vivo
06/26/2008WO2008075006A1 Piperldinum compounds for treatment of obstructive pulmonary diseases ( copd)
06/26/2008WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/26/2008WO2008074450A2 Non-peptidic renin inhibitors nitroderivatives
06/26/2008WO2008002820A3 Substituted benzyl amine compounds
06/26/2008US20080153878 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one ; for therapy of Alzheimer's disease, myasthenia gravis, Huntingtons disease or glaucoma
06/26/2008US20080153851 Cycloalkyl Piperidine Tachykinin Receptor Antagonists
06/26/2008US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists
06/26/2008US20080153843 Bradykinin 1 receptor (B1R) antagonists for treating various inflammatory diseases, pain, obesity; compounds bind to both rat and human receptors for pharmacological testing; ether and amide-functional N-heterocycle sulfonamides
06/26/2008US20080153834 Certain Substituted Amides, Method of Making, and Method of Use Thereof
06/26/2008US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder
06/26/2008US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy
06/26/2008DE20122843U1 Fentanyl Zusammensetzung zur nasalen Anwendung Fentanyl composition for nasal administration
06/26/2008DE102007059495A1 Verfahren zur Addition von Hydrazin an Acrylmakromonomere und Produkte daraus Process for the addition of hydrazine to Acrylmakromonomere and products thereof
06/26/2008CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/25/2008EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
06/25/2008EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues.
06/25/2008EP1935884A2 New crystalline forms of donepezil base
06/25/2008EP1935869A1 Retinoids for the treatment of emphysema
06/25/2008EP1934264A2 Amido-organoborate initiator systems
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 380